Baker Bros. Advisors’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $242M | Buy |
|
|||||
|
2023
Q3 | $61.4M | Hold |
|
|||||
|
2023
Q2 | $50.9M | Hold |
|
|||||
|
2023
Q1 | $52.4M | Hold |
|
|||||
|
2022
Q4 | $63.9M | Hold |
|
|||||
|
2022
Q3 | $98.5M | Hold |
|
|||||
|
2022
Q2 | $94.6M | Hold |
|
|||||
|
2022
Q1 | $116M | Hold |
|
|||||
|
2021
Q4 | $207M | Hold |
|
|||||
|
2021
Q3 | $249M | Hold |
|
|||||
|
2021
Q2 | $228M | Hold |
|
|||||
|
2021
Q1 | $241M | Hold |
|
|||||
|
2020
Q4 | $310M | Hold |
|
|||||
|
2020
Q3 | $234M | Hold |
|
|||||
|
2020
Q2 | $161M | Hold |
|
|||||
|
2020
Q1 | $108M | Buy |
|
|||||
|
2019
Q4 | $168M | Hold |
|
|||||
|
2019
Q3 | $102M | Sell |
|
|||||
|
2019
Q2 | $259M | Hold |
|
|||||
|
2019
Q1 | $184M | Hold |
|
|||||
|
2018
Q4 | $107M | Hold |
|
|||||
|
2018
Q3 | $118M | Hold |
|
|||||
|
2018
Q2 | $124M | Sell |
|
|||||
|
2018
Q1 | $78.3M | Hold |
|
|||||
|
2017
Q4 | $46.5M | Buy |
|
|||||
|
2017
Q3 | $26.5M | Hold |
|
|||||
|
2017
Q2 | $8.28M | Hold |
|
|||||
|
2017
Q1 | $11.8M | Hold |
|
|||||
|
2016
Q4 | $10.8M | Hold |
|
|||||
|
2016
Q3 | $15M | Hold |
|
|||||
|
2016
Q2 | $12.4M | Sell |
|
|||||
|
2016
Q1 | $69.9M | Buy |
|
|||||
|
2015
Q4 | $93.4M | Hold |
|
|||||
|
2015
Q3 | $102M | Buy |
|
|||||
|
2015
Q2 | $88.3M | Hold |
|
|||||
|
2015
Q1 | $82.2M | Buy |
|
|||||
|
2014
Q4 | $44.1M | Hold |
|
|||||
|
2014
Q3 | $41.7M | Hold |
|
|||||
|
2014
Q2 | $47.6M | Hold |
|
|||||
|
2014
Q1 | $45.4M | Hold |
|
|||||
|
2013
Q4 | $39.6M | Buy |
|
|||||
|
2013
Q3 | $30M | Buy |
|